clinical trial · NCT06747143
Short-term Immunomodulatory Effects of Lactobacillus Casei DN-114001: Impacts on Gut Microbiota Composition and Systemic Immune Biomarkers in Healthy Adults
University of Valladolid·N/A·completed·n = 21
Immune ModulationLactobacillus casei DN-114001
brief summary
The study included 21 adult participants, aged 19-46 years (19 female participants and 2 male participants). The selection criteria included the following parameters: Body Mass Index (BMI), calculated as weight (kg) divided by height squared (m²), between 18.5 and 29.99; Waist-to-Hip Ratio with thresholds set at \>0.90 for males and \>0.85 for females for individuals with normal weight (eutrophic); percentage of body fat: Considered within normal range if \<30% for individuals with normal weight. Standard biochemical and anthropometric measurements were carried out to all the subjects.
started
Feb 1, 2013
primary completion
Apr 1, 2013
completion
Sep 1, 2013
last updated
Jan 6, 2025
official title
"Study of Immunological Biomarkers in Response to Probiotic Intake"
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol